Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bishop

Showing results (891-900 of 1,042) with videos related to

Pageof 105
Sort By:
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|March 16, 2016
Sex and diagnosis specific associations between DNA methylation of the oxytocin receptor gene with emotion processing and temporal-limbic and prefrontal brain volumes in psychotic disordersLeah H Rubin, Jessica J Connelly, James L Reilly, et al.
Journal of Neuroscience Research|November 22, 2016
Sex differences in associations of arginine vasopressin and oxytocin with resting-state functional brain connectivityLeah H Rubin, Li Yao, Sarah K Keedy, et al.
Leukemia|October 19, 2011
Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severityL Grkovic, K Baird, S M Steinberg, et al.
Transplantation and Cellular Therapy|April 29, 2023
Patient Characteristics and Outcomes of Outpatient Tisagenlecleucel Recipients for B Cell Non-Hodgkin LymphomaNausheen Ahmed, William Wesson, Muhammad Umair Mushtaq, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 10, 2021
Impact of polygenic risk for coronary artery disease and cardiovascular medication burden on cognitive impairment in psychotic disordersLusi Zhang, Scot Kristian Hill, Bin Guo, et al.
Cancer Chemotherapy and Pharmacology|January 29, 1999
Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude miceM Liu, M S Bryant, J Chen, et al.
Blood Advances|February 20, 2020
Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphomaRichard T Maziarz, Edmund K Waller, Ulrich Jaeger, et al.
Clinical Pharmacology and Therapeutics|April 9, 2023
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor AntidepressantsChad A Bousman, James M Stevenson, Laura B Ramsey, et al.
Bone Marrow Transplantation|December 18, 2007
Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant ResearchM R Bishop, B R Logan, S Gandham, et al.
Blood Advances|April 26, 2024
High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease preventionNoa G Holtzman, Lauren M Curtis, Rachel B Salit, et al.
Pageof 105

Showing results (891-900 of 1,042) with videos related to

Sort By:
Pageof 105
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|March 16, 2016
Sex and diagnosis specific associations between DNA methylation of the oxytocin receptor gene with emotion processing and temporal-limbic and prefrontal brain volumes in psychotic disordersLeah H Rubin, Jessica J Connelly, James L Reilly, et al.
Journal of Neuroscience Research|November 22, 2016
Sex differences in associations of arginine vasopressin and oxytocin with resting-state functional brain connectivityLeah H Rubin, Li Yao, Sarah K Keedy, et al.
Leukemia|October 19, 2011
Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severityL Grkovic, K Baird, S M Steinberg, et al.
Transplantation and Cellular Therapy|April 29, 2023
Patient Characteristics and Outcomes of Outpatient Tisagenlecleucel Recipients for B Cell Non-Hodgkin LymphomaNausheen Ahmed, William Wesson, Muhammad Umair Mushtaq, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 10, 2021
Impact of polygenic risk for coronary artery disease and cardiovascular medication burden on cognitive impairment in psychotic disordersLusi Zhang, Scot Kristian Hill, Bin Guo, et al.
Cancer Chemotherapy and Pharmacology|January 29, 1999
Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude miceM Liu, M S Bryant, J Chen, et al.
Blood Advances|February 20, 2020
Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphomaRichard T Maziarz, Edmund K Waller, Ulrich Jaeger, et al.
Clinical Pharmacology and Therapeutics|April 9, 2023
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor AntidepressantsChad A Bousman, James M Stevenson, Laura B Ramsey, et al.
Bone Marrow Transplantation|December 18, 2007
Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant ResearchM R Bishop, B R Logan, S Gandham, et al.
Blood Advances|April 26, 2024
High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease preventionNoa G Holtzman, Lauren M Curtis, Rachel B Salit, et al.
Pageof 105